SSD MED/38
Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations on the KCNJ11 (KIR6.2)gene / Tonini, G; Bizzarri, C; Bonfanti, R; Vanelli, Maurizio; Cerutti, F; Faleschini, E; Meschi, F; Prisco, F; Ciacco, E; Cappa, M; Torelli, C; Cauvin, V; Tumini, S; Iafusco, D; BARBETTI F., EARLY ONSET DIABETES STUDY GROUP OF THE ITALIAN SOCIETY OF PAEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY. - In: DIABETOLOGIA. - ISSN 0012-186X. - 49 (9):(2006), pp. 2210-2213. [10.1007/s00125-006-0329-x]
Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations on the KCNJ11 (KIR6.2)gene.
VANELLI, Maurizio;
2006-01-01
Abstract
SSD MED/38File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
3, Vanelli, Diabetologia2006, Citation Index39.pdf
non disponibili
Tipologia:
Documento in Post-print
Licenza:
Creative commons
Dimensione
89.74 kB
Formato
Adobe PDF
|
89.74 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
